Skip to content

Press Release · Press Releases

Immunofoco Presents a Novel In Vivo TCE Delivery Strategy Using Lentiviral Vectors at SITC 2026

Issued by PR Newswire

SHANGHAI, Nov. 11, 2026 /PRNewswire/ -- At the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2026), held November 4–8 in Phoenix, Arizona, Immunofoco, in collaboration with Renji Hospital, Shanghai Jiao Tong University School of Medicine, and Shanghai East Hospital,...

This press release summary is reproduced from the issuer's public feed.

Read the full release at PR Newswire

Original publisher: PR Newswire

Spotted an error? Request a correction · Corrections Policy

Related stories